Search
for

    Sort by

    Research 691–720 of 1000+

    1. Analysis of the microRNA expression profile of normal human dermal papilla cells treated with 5α-dihydrotestosterone Molecular Medicine Reports · 2012 · 22 citations
    2. Twice weekly 5 mg betamethasone oral pulse therapy in the treatment of alopecia areata Journal of the European Academy of Dermatology and Venereology · 2006 · 22 citations
    3. Inhibitors of 5α -Reductase Type I in LNCaP Cells from the Roots of Angelica koreana Planta Medica · 2002 · 22 citations
    4. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia. PubMed · 2002 · 20 citations
    5. Novel inhibitors of 5α-reductase Expert Opinion on Therapeutic Patents · 2002 · 20 citations
    6. Synthesis of 5,6,6-[2H3]finasteride and quantitative determination of finasteride in human plasma at picogram level by an isotope-dilution mass spectrometric method Journal of Chromatography B: Biomedical Sciences and Applications · 1995 · 20 citations
    7. Similar response patterns to topical minoxidil foam 5% in frontal and vertex scalp of men with androgenetic alopecia: a microarray analysis British Journal of Dermatology · 2014 · 19 citations
    8. Skin-specific regulation of SREBP processing and lipid biosynthesis by glycerol kinase 5 Proceedings of the National Academy of Sciences of the United States of America · 2017 · 18 citations
    9. Low-dose (2.5 mg/day) finasteride treatment in hirsutism Gynecological Endocrinology · 2003 · 18 citations
    10. FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects The Journal of Steroid Biochemistry and Molecular Biology · 1996 · 17 citations
    11. Effect of the 5α-reductase enzyme inhibitor dutasteride in the brain of intact and parkinsonian mice 2017 · 16 citations
    12. Enhanced skin permeation of 5α-reductase inhibitors entrapped into surface-modified liquid crystalline nanoparticles Archives of Pharmacal Research · 2014 · 16 citations
    13. N-(3,5-Dimethylphenyl)-3-Methoxybenzamide (A3B5) Targets TRP-2 and Inhibits Melanogenesis and Melanoma Growth 2011 · 15 citations
    14. Extramammary Paget disease: Failure to respond to topical imiquimod 5% Journal of the American Academy of Dermatology · 2011 · 14 citations
    15. New approach to 3-oxo-4-aza-5α-androst-1-ene-17β-(--butylcarboxamide) Steroids · 2005 · 14 citations
    16. Inhibition of steroid 5 alpha-reductase with finasteride: sleep-related erections, potency, and libido in healthy men The Journal of Clinical Endocrinology and Metabolism · 1995 · 14 citations
    17. Label-free concurrent 5-modal microscopy (Co5M) resolves unknown spatio-temporal processes in wound healing Communications Biology · 2021 · 13 citations
    18. 3,4,5-Tri-O-Caffeoylquinic Acid Promoted Hair Pigmentation Through β-Catenin and Its Target Genes Frontiers in cell and developmental biology · 2020 · 13 citations
    19. CRISPR/Cas9-mediated Disruption of Fibroblast Growth Factor 5 in Rabbits Results in a Systemic Long Hair Phenotype by Prolonging Anagen Genes · 2020 · 13 citations
    20. Clinical efficacy of oral administration of finasteride at a dose of 2.5 mg/day in women with female pattern hair loss Dermatologic Therapy · 2018 · 13 citations
    21. Syphilitic Alopecia: A Report of 5 Cases and a Review of the Literature Actas Dermo-Sifiliográficas · 2013 · 13 citations
    22. Establishment of type II 5α-reductase over-expressing cell line as an inhibitor screening model 2007 · 12 citations
    23. Activity of type 1 5α-reductase is greater in the follicular infrainfundibulum compared with the epidermis British Journal of Dermatology · 1997 · 12 citations
    24. Finasteride: a 5 alpha-reductase inhibitor. PubMed · 1993 · 12 citations
    25. Null Mutation of 5α-Reductase Type I Gene Alters Ethanol Consumption Patterns in a Sex-Dependent Manner Behavior Genetics · 2014 · 11 citations
    26. [Efficacy and tolerability of 5% minoxidil solution (Carexidil®) in male and female androgenetic alopecia: a 6-month open multicentric study]. PubMed · 2011 · 11 citations
    27. The Long-Term Effect Of Specific Type II 5α-Reductase Inhibition With Finasteride on Bone Mineral Density in Men: Results of a 4-Year Placebo Controlled Trial The Journal of Urology · 2002 · 11 citations
    28. Kinetic analysis of LY320236: competitive inhibitor of type I and non-competitive inhibitor of type II human steroid 5α-reductase The Journal of Steroid Biochemistry and Molecular Biology · 2000 · 11 citations
    29. Is there a role for 5α‐reductase inhibitors in transgender individuals? International Journal of Andrology · 2020 · 10 citations
    30. Finasteride-Induced Inhibition of 5α-Reductase Type 2 Could Lead to Kidney Damage—Animal, Experimental Study International Journal of Environmental Research and Public Health · 2019 · 10 citations